226 related articles for article (PubMed ID: 23226545)
1. Decreased levels of circulating IL17-producing CD161+CCR6+ T cells are associated with graft-versus-host disease after allogeneic stem cell transplantation.
van der Waart AB; van der Velden WJ; van Halteren AG; Leenders MJ; Feuth T; Blijlevens NM; van der Voort R; Dolstra H
PLoS One; 2012; 7(12):e50896. PubMed ID: 23226545
[TBL] [Abstract][Full Text] [Related]
2. CD161(+) T cells as predictive markers for acute graft-versus-host disease.
Lee SE; Lim JY; Yoon JH; Shin SH; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Cho SG; Kim DW; Lee JW; Min WS; Min CK
Biol Blood Marrow Transplant; 2015 Mar; 21(3):421-8. PubMed ID: 25543092
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of pre-transplant circulating CD3
Kim TW; Lee SE; Lim JY; Ryu DB; Jeon YW; Yoon JH; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Cho SG; Kim DW; Lee JW; Min WS; Min CK
Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27910184
[TBL] [Abstract][Full Text] [Related]
4. The loss of CCR6
McGary CS; Alvarez X; Harrington S; Cervasi B; Ryan ES; Iriele RI; Paganini S; Harper JL; Easley K; Silvestri G; Ansari AA; Lichterfeld M; Micci L; Paiardini M
Mucosal Immunol; 2017 Jul; 10(4):1082-1096. PubMed ID: 28051083
[TBL] [Abstract][Full Text] [Related]
5. Dynamic regulation of effector IFN-γ-producing and IL-17-producing T cell subsets in the development of acute graft-versus-host disease.
Zhao K; Ruan S; Yin L; Zhao D; Chen C; Pan B; Zeng L; Li Z; Xu K
Mol Med Rep; 2016 Feb; 13(2):1395-403. PubMed ID: 26647759
[TBL] [Abstract][Full Text] [Related]
6. Identification of a novel subset of human circulating memory CD4(+) T cells that produce both IL-17A and IL-4.
Cosmi L; Maggi L; Santarlasci V; Capone M; Cardilicchia E; Frosali F; Querci V; Angeli R; Matucci A; Fambrini M; Liotta F; Parronchi P; Maggi E; Romagnani S; Annunziato F
J Allergy Clin Immunol; 2010 Jan; 125(1):222-30.e1-4. PubMed ID: 20109749
[TBL] [Abstract][Full Text] [Related]
7. Targeting the IL17 pathway for the prevention of graft-versus-host disease.
van der Waart AB; van der Velden WJ; Blijlevens NM; Dolstra H
Biol Blood Marrow Transplant; 2014 Jun; 20(6):752-9. PubMed ID: 24565991
[TBL] [Abstract][Full Text] [Related]
8. Low levels of peripheral CD161++CD8+ mucosal associated invariant T (MAIT) cells are found in HIV and HIV/TB co-infection.
Wong EB; Akilimali NA; Govender P; Sullivan ZA; Cosgrove C; Pillay M; Lewinsohn DM; Bishai WR; Walker BD; Ndung'u T; Klenerman P; Kasprowicz VO
PLoS One; 2013; 8(12):e83474. PubMed ID: 24391773
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation.
Dander E; Balduzzi A; Zappa G; Lucchini G; Perseghin P; Andrè V; Todisco E; Rahal D; Migliavacca M; Longoni D; Solinas G; Villa A; Berti E; Mina PD; Parma M; Allavena P; Biagi E; Rovelli A; Biondi A; D'Amico G
Transplantation; 2009 Dec; 88(11):1261-72. PubMed ID: 19996925
[TBL] [Abstract][Full Text] [Related]
10. Impact of Aging on the Frequency, Phenotype, and Function of CD161-Expressing T Cells.
van der Geest KSM; Kroesen BJ; Horst G; Abdulahad WH; Brouwer E; Boots AMH
Front Immunol; 2018; 9():752. PubMed ID: 29725326
[TBL] [Abstract][Full Text] [Related]
11. Depletion of pro-inflammatory CD161(+) double negative (CD3(+)CD4(-)CD8(-)) T cells in AIDS patients is ameliorated by expansion of the γδ T cell population.
Singleterry WL; Henderson H; Cruse JM
Exp Mol Pathol; 2012 Feb; 92(1):155-9. PubMed ID: 22100877
[TBL] [Abstract][Full Text] [Related]
12. Age and CD161 expression contribute to inter-individual variation in interleukin-23 response in CD8+ memory human T cells.
Shen H; Zhang W; Abraham C; Cho JH
PLoS One; 2013; 8(3):e57746. PubMed ID: 23469228
[TBL] [Abstract][Full Text] [Related]
13. Analysis of stem-cell-like properties of human CD161++IL-18Rα+ memory CD8+ T cells.
Havenith SH; Yong SL; Henson SM; Piet B; Idu MM; Koch SD; Jonkers RE; Kragten NA; Akbar AN; van Lier RA; ten Berge IJ
Int Immunol; 2012 Oct; 24(10):625-36. PubMed ID: 22836020
[TBL] [Abstract][Full Text] [Related]
14. Loss of Circulating CD8+ CD161
Acquaviva M; Bassani C; Sarno N; Dalla Costa G; Romeo M; Sangalli F; Colombo B; Moiola L; Martinelli V; Comi G; Farina C
Front Immunol; 2019; 10():1922. PubMed ID: 31474991
[TBL] [Abstract][Full Text] [Related]
15. CD161 is a marker of all human IL-17-producing T-cell subsets and is induced by RORC.
Maggi L; Santarlasci V; Capone M; Peired A; Frosali F; Crome SQ; Querci V; Fambrini M; Liotta F; Levings MK; Maggi E; Cosmi L; Romagnani S; Annunziato F
Eur J Immunol; 2010 Aug; 40(8):2174-81. PubMed ID: 20486123
[TBL] [Abstract][Full Text] [Related]
16. Elevated CCR6+ CD4+ T lymphocytes in tissue compared with blood and induction of CCL20 during the asthmatic late response.
Francis JN; Sabroe I; Lloyd CM; Durham SR; Till SJ
Clin Exp Immunol; 2008 Jun; 152(3):440-7. PubMed ID: 18422729
[TBL] [Abstract][Full Text] [Related]
17. Naive and Stem Cell Memory T Cell Subset Recovery Reveals Opposing Reconstitution Patterns in CD4 and CD8 T Cells in Chronic Graft vs. Host Disease.
Soares MV; Azevedo RI; Ferreira IA; Bucar S; Ribeiro AC; Vieira A; Pereira PNG; Ribeiro RM; Ligeiro D; Alho AC; Soares AS; Camacho N; Martins C; Lourenço F; Moreno R; Ritz J; Lacerda JF
Front Immunol; 2019; 10():334. PubMed ID: 30894856
[TBL] [Abstract][Full Text] [Related]
18. The P2X7 receptor antagonist Brilliant Blue G reduces serum human interferon-γ in a humanized mouse model of graft-versus-host disease.
Geraghty NJ; Belfiore L; Ly D; Adhikary SR; Fuller SJ; Varikatt W; Sanderson-Smith ML; Sluyter V; Alexander SI; Sluyter R; Watson D
Clin Exp Immunol; 2017 Oct; 190(1):79-95. PubMed ID: 28665482
[TBL] [Abstract][Full Text] [Related]
19. Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells.
Dusseaux M; Martin E; Serriari N; Péguillet I; Premel V; Louis D; Milder M; Le Bourhis L; Soudais C; Treiner E; Lantz O
Blood; 2011 Jan; 117(4):1250-9. PubMed ID: 21084709
[TBL] [Abstract][Full Text] [Related]
20. CD8+CD44(hi) but not CD4+CD44(hi) memory T cells mediate potent graft antilymphoma activity without GVHD.
Dutt S; Baker J; Kohrt HE; Kambham N; Sanyal M; Negrin RS; Strober S
Blood; 2011 Mar; 117(11):3230-9. PubMed ID: 21239702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
